Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07566377 · ClinicalTrials.gov registry record · Phase 2
Cord Blood Transplantation in Children and Young Adults With Blood Cancer
A Phase 2 study, sponsored by Memorial Sloan Kettering Cancer Center.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 71
- Enrollment target
NCT07566377: Recruiting Phase 2 study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT07566377 is a Phase 2 study that is actively recruiting participants, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 71 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07566377, a Phase 2 study, is actively recruiting participants, sponsored by Memorial Sloan Kettering Cancer Center.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 71 participants
- Enrollment target
Study Summary
The purpose of this study is to find out whether Cord Blood Transplantation/CBT as the first or second transplant is an effective treatment for children and young adults with blood cancer.
Interventions
- DRUG Cyclophosphamide
- DRUG Fludarabine
- RADIATION Total Body Irradiation
- DRUG Clofarabine
- BIOLOGICAL Cord Blood Units
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 71 participants |
| Start Date | 2026-04-28 |
| Est. Completion | 2030-04-28 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07566377
The ClinicalTrials.gov registry entry for NCT07566377 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 71 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Cyclophosphamide is the first listed.
NCT07566377 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07566377 about?
NCT07566377 is a clinical study titled "Cord Blood Transplantation in Children and Young Adults With Blood Cancer". The purpose of this study is to find out whether Cord Blood Transplantation/CBT as the first or second transplant is an effective treatment for children and young adults with blood cancer.
What is the current status of trial NCT07566377?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 71 participants. The study started on 2026-04-28. Estimated completion is 2030-04-28.
What interventions are being tested in trial NCT07566377?
The interventions under investigation include: Cyclophosphamide (DRUG), Fludarabine (DRUG), Total Body Irradiation (RADIATION), Clofarabine (DRUG), Cord Blood Units (BIOLOGICAL).
Who is sponsoring clinical trial NCT07566377?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.